JP2001513812A - 顔面手術におけるレボブピバカインの使用 - Google Patents

顔面手術におけるレボブピバカインの使用

Info

Publication number
JP2001513812A
JP2001513812A JP53826998A JP53826998A JP2001513812A JP 2001513812 A JP2001513812 A JP 2001513812A JP 53826998 A JP53826998 A JP 53826998A JP 53826998 A JP53826998 A JP 53826998A JP 2001513812 A JP2001513812 A JP 2001513812A
Authority
JP
Japan
Prior art keywords
levobupivacaine
surgery
bupivacaine
administered
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53826998A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513812A5 (cg-RX-API-DMAC7.html
Inventor
ジェナリー,ブライアン・アルバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of JP2001513812A publication Critical patent/JP2001513812A/ja
Publication of JP2001513812A5 publication Critical patent/JP2001513812A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP53826998A 1997-03-03 1998-03-03 顔面手術におけるレボブピバカインの使用 Pending JP2001513812A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9704352.5A GB9704352D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
GB9704352.5 1997-03-03
PCT/GB1998/000657 WO1998038996A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in facial surgery

Publications (2)

Publication Number Publication Date
JP2001513812A true JP2001513812A (ja) 2001-09-04
JP2001513812A5 JP2001513812A5 (cg-RX-API-DMAC7.html) 2005-08-11

Family

ID=10808603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53826998A Pending JP2001513812A (ja) 1997-03-03 1998-03-03 顔面手術におけるレボブピバカインの使用

Country Status (20)

Country Link
US (1) US5919804A (cg-RX-API-DMAC7.html)
EP (1) EP0981347B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513812A (cg-RX-API-DMAC7.html)
KR (1) KR100516676B1 (cg-RX-API-DMAC7.html)
CN (1) CN1089585C (cg-RX-API-DMAC7.html)
AT (1) ATE240730T1 (cg-RX-API-DMAC7.html)
AU (1) AU730390B2 (cg-RX-API-DMAC7.html)
BR (1) BR9808303A (cg-RX-API-DMAC7.html)
CA (1) CA2279497C (cg-RX-API-DMAC7.html)
DE (1) DE69814851T2 (cg-RX-API-DMAC7.html)
DK (1) DK0981347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199423T3 (cg-RX-API-DMAC7.html)
GB (1) GB9704352D0 (cg-RX-API-DMAC7.html)
HU (1) HU225151B1 (cg-RX-API-DMAC7.html)
IL (1) IL131084A0 (cg-RX-API-DMAC7.html)
NO (1) NO322446B1 (cg-RX-API-DMAC7.html)
PL (1) PL190900B1 (cg-RX-API-DMAC7.html)
PT (1) PT981347E (cg-RX-API-DMAC7.html)
WO (1) WO1998038996A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA981779B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
ATE239474T1 (de) * 1997-07-22 2003-05-15 Darwin Discovery Ltd Verwendung von levobupivacain
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
ES2397574T3 (es) 2002-07-30 2013-03-08 Omeros Corporation Procedimiento y soluciones de irrigación oftalmológica
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze
US20050176823A1 (en) * 2004-02-10 2005-08-11 Diaz Robert L. Intra-operative procedure for post-operative pain control
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
ZA981779B (en) 1999-03-03
NO994257L (no) 1999-11-02
HK1022651A1 (en) 2000-08-18
ES2199423T3 (es) 2004-02-16
PL335561A1 (en) 2000-05-08
DK0981347T3 (da) 2003-09-15
DE69814851D1 (de) 2003-06-26
HUP0000873A3 (en) 2002-10-28
WO1998038996A1 (en) 1998-09-11
KR20000075896A (ko) 2000-12-26
EP0981347A1 (en) 2000-03-01
DE69814851T2 (de) 2004-01-22
AU6630498A (en) 1998-09-22
US5919804A (en) 1999-07-06
HU225151B1 (en) 2006-07-28
PT981347E (pt) 2003-09-30
PL190900B1 (pl) 2006-02-28
NO322446B1 (no) 2006-10-09
ATE240730T1 (de) 2003-06-15
NO994257D0 (no) 1999-09-02
GB9704352D0 (en) 1997-04-23
CN1249684A (zh) 2000-04-05
HUP0000873A2 (hu) 2000-09-28
IL131084A0 (en) 2001-01-28
BR9808303A (pt) 2000-05-16
EP0981347B1 (en) 2003-05-21
KR100516676B1 (ko) 2005-09-22
CA2279497A1 (en) 1998-09-11
CA2279497C (en) 2009-01-20
AU730390B2 (en) 2001-03-08
CN1089585C (zh) 2002-08-28

Similar Documents

Publication Publication Date Title
US5849763A (en) Use of levobupivacaine as an anesthetic agent
KR100516676B1 (ko) 안면 수술에서의 레보부피바카인의 용도
JP2001510795A (ja) レボブピバカインとその使用
JPH09503778A (ja) 鎮痛剤およびその使用
KR100535554B1 (ko) 소아과 수술에서의 레보부피바카인의 용도
JP2001510794A (ja) レボブピバカインとその使用
AU731127B2 (en) The use of levobupivacaine or ropivacaine in treating migraine
CA2216583C (en) Levobupivacaine and its use as an anaesthetic in pregnant women
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
HUP0100599A2 (hu) Lokális anesztetikumok új alkalmazása vaszkuláris fejfájások ellen
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
MXPA99008055A (es) Uso de levobupivacaina en cirugia facial
HK1022651B (en) The use of levobupivacaine in facial surgery
Khalil et al. Alfentanil decreases the excitatory phenomena of sodium methohexital
KR100413717B1 (ko) 레보부피바카인및임산부의마취제로서그것의용도
Abdelmonem et al. COMPARISON BETWEEN INTRATHECAL ISOBARIC LEVOBUPIVACAINE VERSUS HYPERBARIC BUPIVACAINE IN ELDERLY PATIENTS UNDERGOING TROCHANTERIC FRACTURE SURGERY
UA146303U (uk) Спосіб симптоматичного лікування болю
JP2001131073A (ja) 疼痛治療剤
MXPA99008056A (en) The use of levobupivacaine or ropivacaine in treating migraine
Schug et al. Local anesthetics
JPH09136843A (ja) 血圧上昇薬

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080916

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090303